Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Manitoba Pharmacist Initiated Smoking Cessation Pilot Project

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02554071
Recruitment Status : Completed
First Posted : September 18, 2015
Last Update Posted : September 18, 2015
Sponsor:
Collaborators:
Govenment of Manitoba
Canadian Foundation for Pharmacy
Neighbourhood Pharmacy Association of Canada
Information provided by (Responsible Party):
Dr. Shawn Bugden, University of Manitoba

Brief Summary:
A single arm pilot study conducted to assess the feasibility of having Manitoba Pharmacists provide support (product and cognitive) to low-income (receiving social assistance) smokers wishing to quit smoking.

Condition or disease Intervention/treatment Phase
Smoking Cessation Other: Pharmacist - Smoking Cessation Support Phase 4

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 119 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Manitoba Pharmacist Initiated Smoking Cessation Pilot Project
Study Start Date : January 2014
Actual Primary Completion Date : November 2014
Actual Study Completion Date : November 2014

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Pharmacist - Smoking Cessation Support'
Active Comparator Arm Receive smoking assessment Initial Smoking Cessation Counselling Smoking Cessation Prescription/Non-Prescription Product as required Follow-up Counselling
Other: Pharmacist - Smoking Cessation Support
Intervention mirrors clinical practice with smoking cessation counselling -- patients receive smoking cessation product at no cost and pharmacists are paid flat fee for providing counselling




Primary Outcome Measures :
  1. Smoking Cessation Assessment [ Time Frame: 6 months ]
    Self-reported Smoking Cessation on Standardized Form


Secondary Outcome Measures :
  1. Smoking Cessation Assessment [ Time Frame: 1 month ]
    Self-reported Smoking Cessation on Standardized Form

  2. Smoking Cessation Assessment [ Time Frame: 3 months ]
    Self-reported Smoking Cessation on Standardized Form

  3. Smoking Cessation Product [ Time Frame: 3 months ]
    Smoking Cessation Product Used and Cost

  4. Quit Diary [ Time Frame: 6 months ]
    Record of Continued Smoking and Symptoms


Other Outcome Measures:
  1. Cigarettes Smoked [ Time Frame: day 0, 1 month, 3 months and 6 months ]
    # of cigarettes smoked

  2. Pharmacist Time [ Time Frame: 6 months ]
    Time spent by pharmacists in counselling patients



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • smoker
  • >= 18 years
  • receiving Manitoba Employment and Income Assistance as of January 1st 2015
  • Stated desire to quit smoking
  • Signed Consent with associated agreement to participate in evaluation and follow-up

Exclusion Criteria:

  • < 18
  • Not on Income Assistance
  • Current non-smoker

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02554071


Locations
Layout table for location information
Canada, Manitoba
College of Pharmacy, University of Manitoba
Winnipeg, Manitoba, Canada, R6M 1L4
Sponsors and Collaborators
University of Manitoba
Govenment of Manitoba
Canadian Foundation for Pharmacy
Neighbourhood Pharmacy Association of Canada
Investigators
Layout table for investigator information
Principal Investigator: Shawn C Bugden, PharmD College of Pharmacy, University of Manitoba

Layout table for additonal information
Responsible Party: Dr. Shawn Bugden, Associate Professor, University of Manitoba
ClinicalTrials.gov Identifier: NCT02554071     History of Changes
Other Study ID Numbers: H2013:459
First Posted: September 18, 2015    Key Record Dates
Last Update Posted: September 18, 2015
Last Verified: September 2015